Annual CFF
$4.11 M
-$12.76 M-75.63%
December 31, 2023
Summary
- As of February 7, 2025, TNDM annual cash flow from financing activities is $4.11 million, with the most recent change of -$12.76 million (-75.63%) on December 31, 2023.
- During the last 3 years, TNDM annual CFF has fallen by -$310.32 million (-98.69%).
- TNDM annual CFF is now -98.69% below its all-time high of $314.44 million, reached on December 31, 2020.
Performance
TNDM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$4.52 M
-$1.52 M-50.53%
September 30, 2024
Summary
- As of February 7, 2025, TNDM quarterly cash flow from financing activities is -$4.52 million, with the most recent change of -$1.52 million (-50.53%) on September 30, 2024.
- Over the past year, TNDM quarterly CFF has dropped by -$7.14 million (-272.68%).
- TNDM quarterly CFF is now -101.71% below its all-time high of $263.82 million, reached on June 30, 2020.
Performance
TNDM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$8.68 M
-$2.61 M-23.10%
September 30, 2024
Summary
- As of February 7, 2025, TNDM TTM cash flow from financing activities is $8.68 million, with the most recent change of -$2.61 million (-23.10%) on September 30, 2024.
- Over the past year, TNDM TTM CFF has increased by +$4.57 million (+111.09%).
- TNDM TTM CFF is now -97.24% below its all-time high of $314.44 million, reached on December 31, 2020.
Performance
TNDM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TNDM Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -75.6% | -272.7% | +111.1% |
| 3 y3 years | -98.7% | -214.5% | -0.6% |
| 5 y5 years | -96.5% | -214.5% | -0.6% |
TNDM Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -92.1% | at low | -128.4% | at low | -83.3% | +111.1% |
| 5 y | 5-year | -98.7% | at low | -101.7% | at low | -97.2% | +111.1% |
| alltime | all time | -98.7% | +13.0% | -101.7% | at low | -97.2% | +138.6% |
Tandem Diabetes Care Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.52 M(+50.5%) | $8.68 M(-23.1%) |
| Jun 2024 | - | -$3.00 M(-122.1%) | $11.29 M(-38.1%) |
| Mar 2024 | - | $13.59 M(+419.1%) | $18.24 M(+343.5%) |
| Dec 2023 | $4.11 M(-75.6%) | $2.62 M(-236.9%) | $4.11 M(-45.9%) |
| Sep 2023 | - | -$1.91 M(-148.4%) | $7.60 M(-13.0%) |
| Jun 2023 | - | $3.95 M(-829.8%) | $8.73 M(-32.0%) |
| Mar 2023 | - | -$541.00 K(-108.9%) | $12.84 M(-23.9%) |
| Dec 2022 | $16.88 M(-67.5%) | $6.10 M(-888.1%) | $16.88 M(-36.7%) |
| Sep 2022 | - | -$774.00 K(-109.6%) | $26.66 M(-42.4%) |
| Jun 2022 | - | $8.05 M(+130.0%) | $46.29 M(-10.7%) |
| Mar 2022 | - | $3.50 M(-78.0%) | $51.86 M(-0.1%) |
| Dec 2021 | $51.93 M(-83.5%) | $15.89 M(-15.7%) | $51.93 M(+14.8%) |
| Sep 2021 | - | $18.85 M(+38.4%) | $45.25 M(-19.7%) |
| Jun 2021 | - | $13.62 M(+281.3%) | $56.33 M(-81.6%) |
| Mar 2021 | - | $3.57 M(-61.2%) | $306.53 M(-2.5%) |
| Dec 2020 | $314.44 M(+1199.0%) | $9.20 M(-69.2%) | $314.44 M(+0.9%) |
| Sep 2020 | - | $29.93 M(-88.7%) | $311.65 M(+7.9%) |
| Jun 2020 | - | $263.82 M(+2197.9%) | $288.75 M(+756.2%) |
| Mar 2020 | - | $11.48 M(+78.9%) | $33.73 M(+39.3%) |
| Dec 2019 | $24.21 M(-79.3%) | $6.42 M(-8.8%) | $24.21 M(+22.6%) |
| Sep 2019 | - | $7.03 M(-20.0%) | $19.75 M(-43.2%) |
| Jun 2019 | - | $8.79 M(+348.2%) | $34.76 M(-28.3%) |
| Mar 2019 | - | $1.96 M(+0.3%) | $48.48 M(-58.6%) |
| Dec 2018 | $117.18 M | $1.96 M(-91.1%) | $117.18 M(-9.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $22.05 M(-2.1%) | $129.91 M(+16.1%) |
| Jun 2018 | - | $22.51 M(-68.1%) | $111.85 M(+25.4%) |
| Mar 2018 | - | $70.67 M(+381.4%) | $89.18 M(+120.9%) |
| Dec 2017 | $40.38 M(-22.8%) | $14.68 M(+267.9%) | $40.38 M(-34.3%) |
| Sep 2017 | - | $3.99 M(-2657.7%) | $61.42 M(+6.9%) |
| Jun 2017 | - | -$156.00 K(-100.7%) | $57.47 M(-2.7%) |
| Mar 2017 | - | $21.86 M(-38.8%) | $59.07 M(+12.9%) |
| Dec 2016 | $52.31 M(-23.4%) | $35.73 M(>+9900.0%) | $52.31 M(+193.0%) |
| Sep 2016 | - | $32.00 K(-97.8%) | $17.86 M(-0.3%) |
| Jun 2016 | - | $1.45 M(-90.4%) | $17.92 M(-2.0%) |
| Mar 2016 | - | $15.10 M(+1090.1%) | $18.29 M(-73.2%) |
| Dec 2015 | $68.25 M(+1775.7%) | $1.27 M(+1264.5%) | $68.25 M(-0.5%) |
| Sep 2015 | - | $93.00 K(-94.9%) | $68.63 M(+0.0%) |
| Jun 2015 | - | $1.82 M(-97.2%) | $68.62 M(-0.1%) |
| Mar 2015 | - | $65.07 M(+3853.1%) | $68.68 M(+1787.3%) |
| Dec 2014 | $3.64 M(-97.8%) | $1.65 M(+2010.3%) | $3.64 M(-97.2%) |
| Sep 2014 | - | $78.00 K(-95.9%) | $130.23 M(+0.8%) |
| Jun 2014 | - | $1.89 M(+6892.6%) | $129.14 M(-10.1%) |
| Mar 2014 | - | $27.00 K(-100.0%) | $143.62 M(-13.5%) |
| Dec 2013 | $166.08 M(+249.6%) | $128.24 M(<-9900.0%) | $166.08 M(+338.8%) |
| Sep 2013 | - | -$1.01 M(-106.2%) | $37.85 M(-2.6%) |
| Jun 2013 | - | $16.38 M(-27.2%) | $38.86 M(+72.8%) |
| Mar 2013 | - | $22.49 M | $22.49 M |
| Dec 2012 | $47.51 M(+260.5%) | - | - |
| Dec 2011 | $13.18 M | - | - |
FAQ
- What is Tandem Diabetes Care annual cash flow from financing activities?
- What is the all time high annual CFF for Tandem Diabetes Care?
- What is Tandem Diabetes Care annual CFF year-on-year change?
- What is Tandem Diabetes Care quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Tandem Diabetes Care?
- What is Tandem Diabetes Care quarterly CFF year-on-year change?
- What is Tandem Diabetes Care TTM cash flow from financing activities?
- What is the all time high TTM CFF for Tandem Diabetes Care?
- What is Tandem Diabetes Care TTM CFF year-on-year change?
What is Tandem Diabetes Care annual cash flow from financing activities?
The current annual CFF of TNDM is $4.11 M
What is the all time high annual CFF for Tandem Diabetes Care?
Tandem Diabetes Care all-time high annual cash flow from financing activities is $314.44 M
What is Tandem Diabetes Care annual CFF year-on-year change?
Over the past year, TNDM annual cash flow from financing activities has changed by -$12.76 M (-75.63%)
What is Tandem Diabetes Care quarterly cash flow from financing activities?
The current quarterly CFF of TNDM is -$4.52 M
What is the all time high quarterly CFF for Tandem Diabetes Care?
Tandem Diabetes Care all-time high quarterly cash flow from financing activities is $263.82 M
What is Tandem Diabetes Care quarterly CFF year-on-year change?
Over the past year, TNDM quarterly cash flow from financing activities has changed by -$7.14 M (-272.68%)
What is Tandem Diabetes Care TTM cash flow from financing activities?
The current TTM CFF of TNDM is $8.68 M
What is the all time high TTM CFF for Tandem Diabetes Care?
Tandem Diabetes Care all-time high TTM cash flow from financing activities is $314.44 M
What is Tandem Diabetes Care TTM CFF year-on-year change?
Over the past year, TNDM TTM cash flow from financing activities has changed by +$4.57 M (+111.09%)